Small-cell lung cancer: Patients included in clinical trials are not representative of the patient population as a whole
Open Access
- 1 July 1999
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 10 (7) , 809-816
- https://doi.org/10.1023/a:1008399831512
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Evaluation of the informed consent procedure in cancer patients candidate to immunotherapyEuropean Journal Of Cancer, 1995
- Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy: Final results of a multicentric pilot study from the Groupe Lyonnais d'Oncologie Thoracique (GLOT)Lung Cancer, 1993
- Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapyEuropean Journal Of Cancer, 1993
- Hyperfractionated radiotherapy alternating with multidrug chemotherapy in the treatment of limited small cell lung cancer (SCLC)☆International Journal of Radiation Oncology*Biology*Physics, 1990
- Prognosis at presentation of small cell carcinoma of the lungEuropean Journal of Cancer and Clinical Oncology, 1990
- Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment for cancer.BMJ, 1986
- Physicians’ Reasons for Not Entering Eligible Patients in a Randomized Clinical Trial of Surgery for Breast CancerNew England Journal of Medicine, 1984
- Consent as a Barrier to ResearchNew England Journal of Medicine, 1979
- A New Design for Randomized Clinical TrialsNew England Journal of Medicine, 1979
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958